Skip to content
OCI-AML2
Tissue
外周血
Disease
髓系白血病
Synonyms
OCI/AML-2, OCIAML-2, OCI-AML2, OCI/AML2, OCI AML2, OCIAML2, AML-2, Ontario Cancer Institute-Acute Myeloid Leukemia-2

Documents

OCI-AML2

Cell line · Product number 305609

OCI-AML2 is a human acute myeloid leukemia (AML) cell line derived from the peripheral blood of a patient with acute myeloblastic leukemia without maturat...

US$375.00excl. tax and shipping
In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

OCI-AML2 是一种源自急性髓母细胞白血病(未成熟型,FAB 分类 M1)患者外周血的人源性急性髓系白血病(AML)细胞系。 该细胞系被广泛用作研究AML生物学特性的模型,AML是一种血液系统恶性肿瘤,其特征是骨髓和外周血中未分化髓系前体细胞的克隆性增殖。 OCI-AML2 细胞为白血病发病机制研究、药物筛选以及治疗干预分子靶点的鉴定提供了一个有价值的工具。

OCI-AML2 细胞以悬浮方式生长,并表现出与未成熟髓系细胞一致的特征。这些细胞具有通常与 AML 相关的遗传和分子异常,包括致癌基因和肿瘤抑制基因的突变,以及参与细胞存活、增殖和分化的信号传导通路失调。 研究人员利用该细胞系探究驱动白血病发生的机制,包括转录调节因子和表观遗传修饰因子在维持白血病原始细胞未分化状态中的作用。

该细胞系在临床前研究中对于评估化疗药物、靶向治疗及联合治疗的疗效具有特别重要的价值。它常被用于测试针对关键信号通路的抑制剂,例如FLT3、MEK/ERK和PI3K/AKT/mTOR通路,这些通路对AML细胞的存活和增殖至关重要。 此外,OCI-AML2还被用于耐药性研究以及急性髓系白血病(AML)个性化治疗方案的开发。总体而言,OCI-AML2是一个强大且可靠的模型系统,有助于推进急性髓系白血病的研究并开发新型治疗策略。

Tissue
外周血
Disease
髓系白血病
Synonyms
  • OCI/AML-2
  • OCIAML-2
  • OCI-AML2
  • OCI/AML2
  • OCI AML2
  • OCIAML2
  • AML-2
  • Ontario Cancer Institute-Acute Myeloid Leukemia-2

02Classification

Organism
Human
Sex
Male
Growth properties
Suspension
Biosafety level
1

03Characteristics

Morphology
单个、圆形至椭圆形的细胞
Cell type
上皮细胞
Doubling time
30 小时

04Identifiers

Citation
OCI-AML2(Cytion 产品编号 305609)
NCBI TaxID
9606
Cellosaurus
CVCL_1619

05Expression and susceptibility

Antigen expression
CD3-、CD4+、CD13+、CD15+、CD19-、CD33+、CD34-、cyCD68+、HLA-DR+
Mutational profile
基因融合:AFDN + HGNC,7132,KMT2A,名称=KMT2A-AFDN,MLL-MLLT4,MLL-AF6。

06Handling and culture

Culture medium
Alpha MEM,浓度:2.0 mM 稳定谷氨酰胺,含核苷和脱氧核苷,浓度:1.0 mM 丙酮酸钠,浓度:2.2 g/L NaHCO₃
Incubation atmosphere

37°C, 5%CO2, 加湿环境。

Supplements
在培养基中添加 10% 热灭活 FBS
Seeding density
2 × 10⁶ 个细胞/毫升
Fluid renewal
每周 2 至 3 次
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.

  7. Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.

  8. Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.

07Quality control and cryopreservation

Sterility

使用基于 PCR 的检测方法和基于发光的支原体检测方法排除支原体污染。

为确保没有细菌、真菌或酵母菌污染,每天都要对细胞培养物进行目视检查。

Freeze medium
我们使用完全生长培养基(包括 FBS)+10% DMSO 或 CM-1(Cytion 商品目录编号 800100)作为冷冻保存培养基,以获得足够的解冻后存活率,CM-1(Cytion 商品目录编号 800100)含有优化的渗透保护剂和代谢稳定剂,可提高恢复能力并减少冷冻引起的应激。
Storage conditions

如需长期保存,可将样品瓶放入气相液氮中,温度约为 -150 至 -196 ℃。在-80 °C下保存只能作为转入液氮前的短暂过渡。

Shipping conditions

冷冻保存的细胞系用干冰装运,并用经过验证的隔热包装和足够的制冷剂在整个运输过程中保持约 -78 °C 的温度。收到货后,应立即检查容器,并立即将小瓶转移到适当的储藏室。

08Donor

Donor age
65 岁
Ethnicity
高加索人